Side effects of Mebeverine HCl in details
In therapeutic doses, no adverse effects have
been reported. Rarely allergic reactions (including
rash, urticaria, angioedema), could be noticed.
USE DURING PREGNANCY AND LACTATION:
Animal experiments have failed to show any teratogenic
effects. However, administration of Mebeverine HCl
is to be discouraged during pregnancy.
Mebeverine is not excreted in the milk of lactating
women after therapeutic doses.
For both cases, the medicine should be used with
Mebeverine HCl contraindications
No contraindications have been reported.
Mebeverine HCl does not provoke any atropinic effect and for this reason is not contraindicated in patients with glaucoma or prostatic hypertrophy.
- European Chemicals Agency - ECHA. "mebeverine: The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.". https://echa.europa.eu/ (accessed September 17, 2018).
- NIST. "Benzoic acid, 3,4-dimethoxy-, 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]butyl ester". http://www.nist.gov/srd/nist1a.cfm (accessed September 17, 2018).
- KEGG. "Target-based classification of drugs". http://www.genome.jp/kegg-bin/get_ht... (accessed September 17, 2018).
ReviewsThe results of a survey conducted on ndrugs.com for Mebeverine HCl are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Mebeverine HCl. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported side effectsNo survey data has been collected yet
There are no reviews yet. Be the first to write one!
Information checked by Dr. Sachin Kumar, MD Pharmacology